Target intelligence / Profile preview

Abnormal epileptogenic neural circuit

Molecular classification
Other (Neural circuit/network)
01

Overview

Abnormal epileptogenic neural circuit" refers to pathological changes in brain networks that predispose individuals to recurrent unprovoked seizures characteristic of epilepsy. These abnormalities arise from an imbalance between excitation and inhibition within neuronal networks, leading to excessive synchronization and hypersynchronous firing. The process by which normal brain tissue becomes capable of generating spontaneous seizures is called epileptogenesis. This transformation can be triggered by genetic factors or acquired insults such as traumatic brain injury, stroke, infection, or prolonged seizures. The resulting aberrant circuitry involves maladaptive neurogenesis and synaptic reorganization—such as miswiring of new neurons—which contribute to hyperexcitability[1][2]. While this concept is central to understanding the pathophysiology of epilepsy at a systems level[3], it does not represent a discrete molecular target but rather describes dysfunctional network properties.\n\n> “The end results of the epileptogenic process are best understood as abnormalities of neuronal circuitry and not simply as molecular or cellular abnormalities... The neuronal network models conceive [epilepsy] as being due to results of abnormalities in the neuronal circuitry.”[1]\n\n> “Epileptogenesis... encompasses the transformation of neuronal networks following an initial insult... resulting in a brain capable of generating spontaneous recurrent seizures.”[2]\n\nNote: \nThis entry does not correspond to a single molecule/receptor/protein but instead describes pathological changes at the level of entire neural circuits/networks. Therefore it should be flagged as incorrect for structured drug-target databases focused on canonical molecules/receptors/enzymes/channels.

Other names
Epileptogenic neural circuitAbnormal neuronal circuitry in epilepsyAberrant neural network in epilepsy
02

Mechanism of action

Modulation of neuronal excitability (e.g., via sodium channel blockers, GABAergic enhancers)\nInhibition of hypersynchronous firing\n(These mechanisms are indirect and act on components within the abnormal circuits rather than the circuit itself.)

03

Biological functions

Signal transductionNeuronal synchronizationExcitation-inhibition balanceNetwork plasticity
04

Disease associations

Neurodegenerative disease (specifically, epilepsy)Other (Epilepsy and seizure disorders)
05

Safety considerations

Difficulty targeting without affecting normal brain function

Beyond the preview

Go deeper on Abnormal epileptogenic neural circuit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abnormal epileptogenic neural circuit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call